Support line: +44 (0)1653 699599
A £2.3 million study will investigate the neurological or neuropsychiatric effects of COVID-19 Read more
A statement from the Encephalitis Society in relation to the COVID-19 Vaccine. Developed in collaboration with our Scientific Advisory Panel Read more
This is our homepage for all information about Covid-19 (Coronavirus) and encephalitis.
We will be updating supporters over the coming weeks and months, sharing information about the pandemic, factsheets and updates from the Encephalitis Society.
Our services will be continuing as normal and if you wish to contact our support team, please do so via the website or by calling +44(0)1653 699599.
We will also be regularly updating our social media channels on Facebook, Twitter, LinkedIn, Instagram and YouTube. If you have anything you would like to include, please get in touch.
Best wishes, the Encephalitis Society team.
Make a Donation
We are expecting unprecedented demand for our services over the next six months and may struggle to meet that rise in demand without support from you, our global family of members and supporters.
PLEASE consider making a donation or setting up a regular gift to ensure the Encephalitis Society can continue its life-saving work.
Dr Ava Easton, Chief Executive of the Encephalitis Society
A £2.3 million study will investigate the neurological or neuropsychiatric effects of COVID-19
A message from Dr Ava Easton, the Chief Executive of the Encephalitis Society in response to the Covid-19 outbreak
A statement from the Encephalitis Society on coronavirus and encephalitis. (Updated 19 January 2021)
COVID-19 And The Brain: Are There Neurocognitive Effects Of The Pandemic?
- Professor Huw Williams, Ms Hope Kent, Dr Bonnie-Kate Dewar
Our podcasts regularly look at the impact of COVID-19 on encephalitis, neurology, health and wellbeing.
A list of the latest Covid-19 research papers. Updated regularly.
Can you help? Physicians are needed to describe the neurological features of their Covid-19 patients.
A statement from the Encephalitis Society in relation to the COVID-19 Vaccine. Developed in collaboration with our Scientific Advisory Panel